Publications by authors named "May Mo"

Claim this Profile
B
Bayesian network meta-regression for aggregate ordinal outcomes with imprecise categories.
Yeongjin Gwon, Ming-Hui Chen, May Mo, Xun Jiang, H Amy Xia

J Biopharm Stat· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving power in adaptive expansion of biomarker populations in phase 3 clinical trials.
Guoqing Diao, Xun Jiang, Donglin Zeng, May Mo, H Amy Xia

J Biopharm Stat· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Control arm augmentation and hierarchical modeling in time-to-event trials: advantages and pitfalls.
Ethan M Alt, Xiuya Chang, Qing Liu, Xun Jiang, May Mo

Biostatistics· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rejoinder to the discussion on "LEAP: the latent exchangeability prior for borrowing information from historical data".
Ethan M Alt, Xiuya Chang, Xun Jiang, Qing Liu, May Mo

Biometrics· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LEAP: the latent exchangeability prior for borrowing information from historical data.
Ethan M Alt, Xiuya Chang, Xun Jiang, Qing Liu, May Mo

Biometrics· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving resource utilisation in SLE drug development through innovative trial design.
Sandra Garces, Elaine Karis, Joan T Merrill, Anca D Askanase, Kenneth Kalunian, May Mo, Cassandra E Milmont

Lupus Sci Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic/pharmacodynamic data extrapolation models for improved pediatric efficacy and toxicity estimation, with application to secondary hyperparathyroidism.
Cynthia Basu, Xiaoye Ma, May Mo, Hong Amy Xia, Richard Brundage, Mahmoud Al-Kofahi

Pharm Stat· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma.
Michael E Wechsler, Gene Colice, Janet M Griffiths, Gun Almqvist, Tor Skärby, May Mo

Respir Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma.
Andrew Menzies-Gow, Gene Colice, Janet M Griffiths, Gun Almqvist, Sandhia Ponnarambil, May Mo

Respir Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis.
Bradley A Warady, Eric Ng, Laura Bloss, May Mo, Franz Schaefer

Pediatr Nephrol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Network meta-regression for ordinal outcomes: Applications in comparing Crohn's disease treatments.
Yeongjin Gwon, May Mo, Ming-Hui Chen, Zhiyi Chi, Juan Li

Stat Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations in testing treatment effects on transient event driven health status changes measured by patient reported outcomes.
Jingyuan Liu, Jason C Legg, May Mo, Xuwen Zhang

Stat Med· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tezepelumab, an anti-thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trial.
Eric L Simpson, Jane R Parnes, Dewei She, Sarah Crouch, William Rees, May Mo

J Am Acad Dermatol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tezepelumab in Adults with Uncontrolled Asthma.
Jonathan Corren, Jane R Parnes, Liangwei Wang, May Mo, Stephanie L Roseti

N Engl J Med· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective analysis of relative dose intensity in patients with non-Hodgkin lymphoma receiving CHOP-based chemotherapy and pegfilgrastim.
Lodovico Balducci, May Mo, Esteban Abella, Alan Saven

Am J Clin Oncol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence-based diagnosis and treatment for specific learning disabilities involving impairments in written and/or oral language.
Virginia W Berninger, Maggie O'Malley May

J Learn Disabil· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study.
Quynh-Thu Le, Harold E Kim, Charles J Schneider, Györgyi Muraközy, Krzysztof Skladowski, May Mo, Mon-Gy Chen

J Clin Oncol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, placebo-controlled phase ii study evaluating the reduction of neutropenia and febrile neutropenia in patients with colorectal cancer receiving pegfilgrastim with every-2-week chemotherapy.
J Randolph Hecht, Madhavan Pillai, Russell Gollard, William Heim, Forrest Swan, May Mo

Clin Colorectal Cancer· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of different sample matrices for evaluating functional sensitivity, imprecision and dilution linearity of the Abbott ARCHITECT i2000 TSH assay.
Frank A Quinn, Richard Scopp, Agnes Lach, Christopher Drake, May Mo

Clin Chem Lab Med· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis